Veraguensin
Veraguensin is a lignan compound derived from Magnolia sp.. Veraguensin can inhibit bone resorption[1]
Product Specifications
CAS Number
[19950-55-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/veraguensin.html
Purity
99.89
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C[C@H]1[C@H](C)[C@H](C2=CC=C(OC)C(OC)=C2)O[C@@H]1C3=CC=C(OC)C(OC)=C3
Molecular Formula
C22H28O5
Molecular Weight
372.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Asai M, et al. Effects of veraguensin and galgravin on osteoclast differentiation and function. Cytotechnology. 2012 May;64 (3) :315-22.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15163693 1 Vial
Lentiviral human PAIP1 shRNA (UAS) - Lentiviral human PAIP1 shRNA (UAS, RFP) plasmid
Ask
View Details 
